The CDK4/6 inhibitor in HR-positive advanced breast cancer: A systematic review and meta-analysis

Ding, W; Li, ZA; Wang, CY; Ruan, GD; Chen, LP; Tu, CJ

Tu, CJ (reprint author), Shaoxing Keqiao Women & Childrens Hosp, Dept Surg, Shaoxing, Peoples R China.

MEDICINE, 2018; 97 (20):

Abstract

Background:Recently, several high-quality clinical randomized controlled trials (RCTs) have identified that cyclin-dependent kinases (CDKs) 4/6 inhibi......

Full Text Link